Robert W. Baird Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $20.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective cut by Robert W. Baird from $22.00 to $20.00 in a report issued on Friday morning,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

A number of other equities research analysts also recently issued reports on the company. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Wells Fargo & Company began coverage on DENTSPLY SIRONA in a research note on Friday, February 14th. They set an “equal weight” rating and a $20.00 price target for the company. Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target for the company. Finally, Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $23.58.

DENTSPLY SIRONA Trading Down 3.5 %

DENTSPLY SIRONA stock opened at $16.55 on Friday. The business has a 50-day simple moving average of $18.88 and a two-hundred day simple moving average of $21.55. The company has a market cap of $3.29 billion, a P/E ratio of -8.00, a P/E/G ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a 52-week low of $16.21 and a 52-week high of $34.91. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.87%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in DENTSPLY SIRONA by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after purchasing an additional 65,478 shares during the period. First Eagle Investment Management LLC boosted its stake in DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after purchasing an additional 348,532 shares during the period. Nuance Investments LLC increased its holdings in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after buying an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after buying an additional 314,343 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.